Report Cover

Global and United States Diabetic Lancing Device Market Insights, Forecast to 2026


Diabetic Lancing Device market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Lancing Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Diabetic Lancing Device market is segmented into
    Push Button Safety Lancets
    Pressure Activated Safety Lancets
    Side Button Safety Lancets

Segment by Application, the Diabetic Lancing Device market is segmented into
    Hospitals
    Clinics

Regional and Country-level Analysis
The Diabetic Lancing Device market is analysed and market size information is provided by regions (countries).
The key regions covered in the Diabetic Lancing Device market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Diabetic Lancing Device Market Share Analysis
Diabetic Lancing Device market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diabetic Lancing Device business, the date to enter into the Diabetic Lancing Device market, Diabetic Lancing Device product introduction, recent developments, etc.
The major vendors covered:
    B. Braun
    Terumo Corporation
    Becton Dickinson
    Sanofi
    Roche
    Bayer
    Novo Nordisk
    Eli Lilly
    Medtronic
    Ypsomed Holding
    Sarstedt
    Abbott Laboratories
    HTL-STREFA
    Improve Medical
    UltiMed
    Allison Medical
    Artsana
1 Study Coverage
    1.1 Diabetic Lancing Device Product Introduction
    1.2 Market Segments
    1.3 Key Diabetic Lancing Device Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Diabetic Lancing Device Market Size Growth Rate by Type
        1.4.2 Push Button Safety Lancets
        1.4.3 Pressure Activated Safety Lancets
        1.4.4 Side Button Safety Lancets
    1.5 Market by Application
        1.5.1 Global Diabetic Lancing Device Market Size Growth Rate by Application
        1.5.2 Hospitals
        1.5.3 Clinics
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Diabetic Lancing Device Market Size, Estimates and Forecasts
        2.1.1 Global Diabetic Lancing Device Revenue 2015-2026
        2.1.2 Global Diabetic Lancing Device Sales 2015-2026
    2.2 Global Diabetic Lancing Device, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Diabetic Lancing Device Historical Market Size by Region (2015-2020)
        2.3.1 Global Diabetic Lancing Device Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Diabetic Lancing Device Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Diabetic Lancing Device Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Diabetic Lancing Device Sales Forecast by Region (2021-2026)
        2.4.2 Global Diabetic Lancing Device Revenue Forecast by Region (2021-2026)

3 Global Diabetic Lancing Device Competitor Landscape by Players
    3.1 Global Top Diabetic Lancing Device Sales by Manufacturers
        3.1.1 Global Diabetic Lancing Device Sales by Manufacturers (2015-2020)
        3.1.2 Global Diabetic Lancing Device Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Diabetic Lancing Device Manufacturers by Revenue
        3.2.1 Global Diabetic Lancing Device Revenue by Manufacturers (2015-2020)
        3.2.2 Global Diabetic Lancing Device Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Diabetic Lancing Device Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Diabetic Lancing Device Revenue in 2019
        3.2.5 Global Diabetic Lancing Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Diabetic Lancing Device Price by Manufacturers
    3.4 Global Diabetic Lancing Device Manufacturing Base Distribution, Product Types
        3.4.1 Diabetic Lancing Device Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Diabetic Lancing Device Product Type
        3.4.3 Date of International Manufacturers Enter into Diabetic Lancing Device Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Diabetic Lancing Device Market Size by Type (2015-2020)
        4.1.1 Global Diabetic Lancing Device Sales by Type (2015-2020)
        4.1.2 Global Diabetic Lancing Device Revenue by Type (2015-2020)
        4.1.3 Diabetic Lancing Device Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Diabetic Lancing Device Market Size Forecast by Type (2021-2026)
        4.2.1 Global Diabetic Lancing Device Sales Forecast by Type (2021-2026)
        4.2.2 Global Diabetic Lancing Device Revenue Forecast by Type (2021-2026)
        4.2.3 Diabetic Lancing Device Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Diabetic Lancing Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Diabetic Lancing Device Market Size by Application (2015-2020)
        5.1.1 Global Diabetic Lancing Device Sales by Application (2015-2020)
        5.1.2 Global Diabetic Lancing Device Revenue by Application (2015-2020)
        5.1.3 Diabetic Lancing Device Price by Application (2015-2020)
    5.2 Diabetic Lancing Device Market Size Forecast by Application (2021-2026)
        5.2.1 Global Diabetic Lancing Device Sales Forecast by Application (2021-2026)
        5.2.2 Global Diabetic Lancing Device Revenue Forecast by Application (2021-2026)
        5.2.3 Global Diabetic Lancing Device Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
    6.1 United States Diabetic Lancing Device Market Size YoY Growth 2015-2026
        6.1.1 United States Diabetic Lancing Device Sales YoY Growth 2015-2026
        6.1.2 United States Diabetic Lancing Device Revenue YoY Growth 2015-2026
        6.1.3 United States Diabetic Lancing Device Market Share in Global Market 2015-2026
    6.2 United States Diabetic Lancing Device Market Size by Players (International and Local Players)
        6.2.1 United States Top Diabetic Lancing Device Players by Sales (2015-2020)
        6.2.2 United States Top Diabetic Lancing Device Players by Revenue (2015-2020)
    6.3 United States Diabetic Lancing Device Historic Market Review by Type (2015-2020)
        6.3.1 United States Diabetic Lancing Device Sales Market Share by Type (2015-2020)
        6.3.2 United States Diabetic Lancing Device Revenue Market Share by Type (2015-2020)
        6.3.3 United States Diabetic Lancing Device Price by Type (2015-2020)
    6.4 United States Diabetic Lancing Device Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 United States Diabetic Lancing Device Sales Forecast by Type (2021-2026)
        6.4.2 United States Diabetic Lancing Device Revenue Forecast by Type (2021-2026)
        6.4.3 United States Diabetic Lancing Device Price Forecast by Type (2021-2026)
    6.5 United States Diabetic Lancing Device Historic Market Review by Application (2015-2020)
        6.5.1 United States Diabetic Lancing Device Sales Market Share by Application (2015-2020)
        6.5.2 United States Diabetic Lancing Device Revenue Market Share by Application (2015-2020)
        6.5.3 United States Diabetic Lancing Device Price by Application (2015-2020)
    6.6 United States Diabetic Lancing Device Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 United States Diabetic Lancing Device Sales Forecast by Application (2021-2026)
        6.6.2 United States Diabetic Lancing Device Revenue Forecast by Application (2021-2026)
        6.6.3 United States Diabetic Lancing Device Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Diabetic Lancing Device Market Size YoY Growth 2015-2026
    7.2 North America Diabetic Lancing Device Market Facts & Figures by Country
        7.2.1 North America Diabetic Lancing Device Sales by Country (2015-2020)
        7.2.2 North America Diabetic Lancing Device Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Diabetic Lancing Device Market Size YoY Growth 2015-2026
    8.2 Europe Diabetic Lancing Device Market Facts & Figures by Country
        8.2.1 Europe Diabetic Lancing Device Sales by Country
        8.2.2 Europe Diabetic Lancing Device Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Diabetic Lancing Device Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Diabetic Lancing Device Market Facts & Figures by Country
        9.2.1 Asia Pacific Diabetic Lancing Device Sales by Region (2015-2020)
        9.2.2 Asia Pacific Diabetic Lancing Device Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Diabetic Lancing Device Market Size YoY Growth 2015-2026
    10.2 Latin America Diabetic Lancing Device Market Facts & Figures by Country
        10.2.1 Latin America Diabetic Lancing Device Sales by Country
        10.2.2 Latin America Diabetic Lancing Device Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Diabetic Lancing Device Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Diabetic Lancing Device Market Facts & Figures by Country
        11.2.1 Middle East and Africa Diabetic Lancing Device Sales by Country
        11.2.2 Middle East and Africa Diabetic Lancing Device Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 B. Braun
        12.1.1 B. Braun Corporation Information
        12.1.2 B. Braun Description and Business Overview
        12.1.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 B. Braun Diabetic Lancing Device Products Offered
        12.1.5 B. Braun Recent Development
    12.2 Terumo Corporation
        12.2.1 Terumo Corporation Corporation Information
        12.2.2 Terumo Corporation Description and Business Overview
        12.2.3 Terumo Corporation Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Terumo Corporation Diabetic Lancing Device Products Offered
        12.2.5 Terumo Corporation Recent Development
    12.3 Becton Dickinson
        12.3.1 Becton Dickinson Corporation Information
        12.3.2 Becton Dickinson Description and Business Overview
        12.3.3 Becton Dickinson Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Becton Dickinson Diabetic Lancing Device Products Offered
        12.3.5 Becton Dickinson Recent Development
    12.4 Sanofi
        12.4.1 Sanofi Corporation Information
        12.4.2 Sanofi Description and Business Overview
        12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Sanofi Diabetic Lancing Device Products Offered
        12.4.5 Sanofi Recent Development
    12.5 Roche
        12.5.1 Roche Corporation Information
        12.5.2 Roche Description and Business Overview
        12.5.3 Roche Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Roche Diabetic Lancing Device Products Offered
        12.5.5 Roche Recent Development
    12.6 Bayer
        12.6.1 Bayer Corporation Information
        12.6.2 Bayer Description and Business Overview
        12.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Bayer Diabetic Lancing Device Products Offered
        12.6.5 Bayer Recent Development
    12.7 Novo Nordisk
        12.7.1 Novo Nordisk Corporation Information
        12.7.2 Novo Nordisk Description and Business Overview
        12.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 Novo Nordisk Diabetic Lancing Device Products Offered
        12.7.5 Novo Nordisk Recent Development
    12.8 Eli Lilly
        12.8.1 Eli Lilly Corporation Information
        12.8.2 Eli Lilly Description and Business Overview
        12.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 Eli Lilly Diabetic Lancing Device Products Offered
        12.8.5 Eli Lilly Recent Development
    12.9 Medtronic
        12.9.1 Medtronic Corporation Information
        12.9.2 Medtronic Description and Business Overview
        12.9.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Medtronic Diabetic Lancing Device Products Offered
        12.9.5 Medtronic Recent Development
    12.10 Ypsomed Holding
        12.10.1 Ypsomed Holding Corporation Information
        12.10.2 Ypsomed Holding Description and Business Overview
        12.10.3 Ypsomed Holding Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Ypsomed Holding Diabetic Lancing Device Products Offered
        12.10.5 Ypsomed Holding Recent Development
    12.11 B. Braun
        12.11.1 B. Braun Corporation Information
        12.11.2 B. Braun Description and Business Overview
        12.11.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 B. Braun Diabetic Lancing Device Products Offered
        12.11.5 B. Braun Recent Development
    12.12 Abbott Laboratories
        12.12.1 Abbott Laboratories Corporation Information
        12.12.2 Abbott Laboratories Description and Business Overview
        12.12.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
        12.12.4 Abbott Laboratories Products Offered
        12.12.5 Abbott Laboratories Recent Development
    12.13 HTL-STREFA
        12.13.1 HTL-STREFA Corporation Information
        12.13.2 HTL-STREFA Description and Business Overview
        12.13.3 HTL-STREFA Sales, Revenue and Gross Margin (2015-2020)
        12.13.4 HTL-STREFA Products Offered
        12.13.5 HTL-STREFA Recent Development
    12.14 Improve Medical
        12.14.1 Improve Medical Corporation Information
        12.14.2 Improve Medical Description and Business Overview
        12.14.3 Improve Medical Sales, Revenue and Gross Margin (2015-2020)
        12.14.4 Improve Medical Products Offered
        12.14.5 Improve Medical Recent Development
    12.15 UltiMed
        12.15.1 UltiMed Corporation Information
        12.15.2 UltiMed Description and Business Overview
        12.15.3 UltiMed Sales, Revenue and Gross Margin (2015-2020)
        12.15.4 UltiMed Products Offered
        12.15.5 UltiMed Recent Development
    12.16 Allison Medical
        12.16.1 Allison Medical Corporation Information
        12.16.2 Allison Medical Description and Business Overview
        12.16.3 Allison Medical Sales, Revenue and Gross Margin (2015-2020)
        12.16.4 Allison Medical Products Offered
        12.16.5 Allison Medical Recent Development
    12.17 Artsana
        12.17.1 Artsana Corporation Information
        12.17.2 Artsana Description and Business Overview
        12.17.3 Artsana Sales, Revenue and Gross Margin (2015-2020)
        12.17.4 Artsana Products Offered
        12.17.5 Artsana Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Diabetic Lancing Device Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Diabetic Lancing Device Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Diabetic Lancing Device Market Segments Table 2. Ranking of Global Top Diabetic Lancing Device Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Diabetic Lancing Device Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Push Button Safety Lancets Table 5. Major Manufacturers of Pressure Activated Safety Lancets Table 6. Major Manufacturers of Side Button Safety Lancets Table 7. Global Diabetic Lancing Device Market Size Growth Rate by Application 2020-2026 (K Units) Table 8. Global Diabetic Lancing Device Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 9. Global Diabetic Lancing Device Sales by Regions 2015-2020 (K Units) Table 10. Global Diabetic Lancing Device Sales Market Share by Regions (2015-2020) Table 11. Global Diabetic Lancing Device Revenue by Regions 2015-2020 (US$ Million) Table 12. Global Diabetic Lancing Device Sales Forecast by Region (2021-2026) (K Units) Table 13. Global Diabetic Lancing Device Sales by Manufacturers (2015-2020) (K Units) Table 14. Global Diabetic Lancing Device Sales Share by Manufacturers (2015-2020) Table 15. Global Diabetic Lancing Device Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Diabetic Lancing Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Lancing Device as of 2019) Table 17. Diabetic Lancing Device Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Diabetic Lancing Device Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Diabetic Lancing Device Price (2015-2020) (USD/Unit) Table 20. Diabetic Lancing Device Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Diabetic Lancing Device Product Type Table 22. Date of International Manufacturers Enter into Diabetic Lancing Device Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Diabetic Lancing Device Sales by Type (2015-2020) (K Units) Table 25. Global Diabetic Lancing Device Sales Share by Type (2015-2020) Table 26. Global Diabetic Lancing Device Revenue by Type (2015-2020) (US$ Million) Table 27. Global Diabetic Lancing Device Revenue Share by Type (2015-2020) Table 28. Diabetic Lancing Device Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 29. Global Diabetic Lancing Device Sales Share by Type (2021-2026) Table 30. Global Diabetic Lancing Device Sales by Application (2015-2020) (K Units) Table 31. Global Diabetic Lancing Device Sales Share by Application (2015-2020) Table 32. Global Diabetic Lancing Device Sales Share by Application (2021-2026) Table 33. Global Diabetic Lancing Device Sales Market Share Forecast by Application (2021-2026) Table 34. Global Diabetic Lancing Device Revenue by Application (2015-2020) (US$ Million) Table 35. Global Diabetic Lancing Device Revenue Market Share Forecast by Application (2021-2026) Table 36. United States Diabetic Lancing Device Sales (K Units) of Key Companies (2015-2020) Table 37. United States Diabetic Lancing Device Sales Share by Company (2015-2020) Table 38. United States Diabetic Lancing Device Revenue (US$ Million) by Company (2015-2020) Table 39. United States Diabetic Lancing Device Sales (K Units) by Type (2015-2020) Table 40. United States Diabetic Lancing Device Sales Share by Type (2015-2020) Table 41. United States Diabetic Lancing Device Revenue (US$ Million) Market Share by Type (2015-2020) Table 42. United States Diabetic Lancing Device Price (K Units) by Type (2015-2020) Table 43. United States Diabetic Lancing Device Sales (K Units) by Type (2021-2026) Table 44. United States Diabetic Lancing Device Sales Share by Type (2021-2026) Table 45. United States Diabetic Lancing Device Revenue (US$ Million) Market Share by Type (2021-2026) Table 46. United States Diabetic Lancing Device Revenue Share by Type (2021-2026) Table 47. United States Diabetic Lancing Device Price (K Units) by Type (2021-2026) Table 48. United States Diabetic Lancing Device Sales (K Units) by Application (2015-2020) Table 49. United States Diabetic Lancing Device Sales Share by Application (2015-2020) Table 50. United States Diabetic Lancing Device Revenue (US$ Million) Market Share by Application (2015-2020) Table 51. United States Diabetic Lancing Device Sales (K Units) by Application (2021-2026) Table 52. United States Diabetic Lancing Device Sales Share by Application (2021-2026) Table 53. United States Diabetic Lancing Device Revenue (US$ Million) Market Share by Application (2021-2026) Table 54. United States Diabetic Lancing Device Revenue Share by Application (2021-2026) Table 55. North America Diabetic Lancing Device Sales by Country (2015-2020) (K Units) Table 56. North America Diabetic Lancing Device Sales Market Share by Country (2015-2020) Table 57. North America Diabetic Lancing Device Revenue by Country (2015-2020) (US$ Million) Table 58. North America Diabetic Lancing Device Revenue Market Share by Country (2015-2020) Table 59. Europe Diabetic Lancing Device Sales by Country (2015-2020) (K Units) Table 60. Europe Diabetic Lancing Device Sales Market Share by Country (2015-2020) Table 61. Europe Diabetic Lancing Device Revenue by Country (2015-2020) (US$ Million) Table 62. Europe Diabetic Lancing Device Revenue Market Share by Country (2015-2020) Table 63. Asia Pacific Diabetic Lancing Device Sales by Region (2015-2020) (K Units) Table 64. Asia Pacific Diabetic Lancing Device Sales Market Share by Region (2015-2020) Table 65. Asia Pacific Diabetic Lancing Device Revenue by Region (2015-2020) (US$ Million) Table 66. Asia Pacific Diabetic Lancing Device Revenue Market Share by Region (2015-2020) Table 67. Latin America Diabetic Lancing Device Sales by Country (2015-2020) (K Units) Table 68. Latin America Diabetic Lancing Device Sales Market Share by Country (2015-2020) Table 69. Latin Americaa Diabetic Lancing Device Revenue by Country (2015-2020) (US$ Million) Table 70. Latin America Diabetic Lancing Device Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Diabetic Lancing Device Sales by Country (2015-2020) (K Units) Table 72. Middle East and Africa Diabetic Lancing Device Sales Market Share by Country (2015-2020) Table 73. Middle East and Africa Diabetic Lancing Device Revenue by Country (2015-2020) (US$ Million) Table 74. Middle East and Africa Diabetic Lancing Device Revenue Market Share by Country (2015-2020) Table 75. B. Braun Corporation Information Table 76. B. Braun Description and Business Overview Table 77. B. Braun Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. B. Braun Diabetic Lancing Device Product Table 79. B. Braun Recent Development Table 80. Terumo Corporation Corporation Information Table 81. Terumo Corporation Description and Business Overview Table 82. Terumo Corporation Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Terumo Corporation Product Table 84. Terumo Corporation Recent Development Table 85. Becton Dickinson Corporation Information Table 86. Becton Dickinson Description and Business Overview Table 87. Becton Dickinson Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Becton Dickinson Product Table 89. Becton Dickinson Recent Development Table 90. Sanofi Corporation Information Table 91. Sanofi Description and Business Overview Table 92. Sanofi Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Sanofi Product Table 94. Sanofi Recent Development Table 95. Roche Corporation Information Table 96. Roche Description and Business Overview Table 97. Roche Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Roche Product Table 99. Roche Recent Development Table 100. Bayer Corporation Information Table 101. Bayer Description and Business Overview Table 102. Bayer Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Bayer Product Table 104. Bayer Recent Development Table 105. Novo Nordisk Corporation Information Table 106. Novo Nordisk Description and Business Overview Table 107. Novo Nordisk Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Novo Nordisk Product Table 109. Novo Nordisk Recent Development Table 110. Eli Lilly Corporation Information Table 111. Eli Lilly Description and Business Overview Table 112. Eli Lilly Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Eli Lilly Product Table 114. Eli Lilly Recent Development Table 115. Medtronic Corporation Information Table 116. Medtronic Description and Business Overview Table 117. Medtronic Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. Medtronic Product Table 119. Medtronic Recent Development Table 120. Ypsomed Holding Corporation Information Table 121. Ypsomed Holding Description and Business Overview Table 122. Ypsomed Holding Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Ypsomed Holding Product Table 124. Ypsomed Holding Recent Development Table 125. Sarstedt Corporation Information Table 126. Sarstedt Description and Business Overview Table 127. Sarstedt Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. Sarstedt Product Table 129. Sarstedt Recent Development Table 130. Abbott Laboratories Corporation Information Table 131. Abbott Laboratories Description and Business Overview Table 132. Abbott Laboratories Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 133. Abbott Laboratories Product Table 134. Abbott Laboratories Recent Development Table 135. HTL-STREFA Corporation Information Table 136. HTL-STREFA Description and Business Overview Table 137. HTL-STREFA Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 138. HTL-STREFA Product Table 139. HTL-STREFA Recent Development Table 140. Improve Medical Corporation Information Table 141. Improve Medical Description and Business Overview Table 142. Improve Medical Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 143. Improve Medical Product Table 144. Improve Medical Recent Development Table 145. UltiMed Corporation Information Table 146. UltiMed Description and Business Overview Table 147. UltiMed Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 148. UltiMed Product Table 149. UltiMed Recent Development Table 150. Allison Medical Corporation Information Table 151. Allison Medical Description and Business Overview Table 152. Allison Medical Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 153. Allison Medical Product Table 154. Allison Medical Recent Development Table 155. Artsana Corporation Information Table 156. Artsana Description and Business Overview Table 157. Artsana Diabetic Lancing Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 158. Artsana Product Table 159. Artsana Recent Development Table 160. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 161. Key Challenges Table 162. Market Risks Table 163. Main Points Interviewed from Key Diabetic Lancing Device Players Table 164. Diabetic Lancing Device Customers List Table 165. Diabetic Lancing Device Distributors List Table 166. Research Programs/Design for This Report Table 167. Key Data Information from Secondary Sources Table 168. Key Data Information from Primary Sources List of Figures Figure 1. Diabetic Lancing Device Product Picture Figure 2. Global Diabetic Lancing Device Sales Market Share by Type in 2020 & 2026 Figure 3. Push Button Safety Lancets Product Picture Figure 4. Pressure Activated Safety Lancets Product Picture Figure 5. Side Button Safety Lancets Product Picture Figure 6. Global Diabetic Lancing Device Sales Market Share by Application in 2020 & 2026 Figure 7. Hospitals Figure 8. Clinics Figure 9. Diabetic Lancing Device Report Years Considered Figure 10. Global Diabetic Lancing Device Market Size 2015-2026 (US$ Million) Figure 11. Global Diabetic Lancing Device Sales 2015-2026 (K Units) Figure 12. Global Diabetic Lancing Device Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Diabetic Lancing Device Sales Market Share by Region (2015-2020) Figure 14. Global Diabetic Lancing Device Sales Market Share by Region in 2019 Figure 15. Global Diabetic Lancing Device Revenue Market Share by Region (2015-2020) Figure 16. Global Diabetic Lancing Device Revenue Market Share by Region in 2019 Figure 17. Global Diabetic Lancing Device Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Diabetic Lancing Device Revenue in 2019 Figure 19. Diabetic Lancing Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Diabetic Lancing Device Sales Market Share by Type (2015-2020) Figure 21. Global Diabetic Lancing Device Sales Market Share by Type in 2019 Figure 22. Global Diabetic Lancing Device Revenue Market Share by Type (2015-2020) Figure 23. Global Diabetic Lancing Device Revenue Market Share by Type in 2019 Figure 24. Global Diabetic Lancing Device Market Share by Price Range (2015-2020) Figure 25. Global Diabetic Lancing Device Sales Market Share by Application (2015-2020) Figure 26. Global Diabetic Lancing Device Sales Market Share by Application in 2019 Figure 27. Global Diabetic Lancing Device Revenue Market Share by Application (2015-2020) Figure 28. Global Diabetic Lancing Device Revenue Market Share by Application in 2019 Figure 29. United States Diabetic Lancing Device Sales Growth Rate 2015-2026 (K Units) Figure 30. United States Diabetic Lancing Device Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. United States Diabetic Lancing Device Market Share in Global Market 2015-2026 Figure 32. United States 5 and 10 Largest Diabetic Lancing Device Players Market Share by Revenue in Diabetic Lancing Device in 2019 Figure 33. United States Diabetic Lancing Device Revenue Share by Type (2015-2020) Figure 34. United States Diabetic Lancing Device Revenue Growth Rate by Type in 2015 & 2019 Figure 35. United States Diabetic Lancing Device Revenue Share by Application (2015-2020) Figure 36. United States Diabetic Lancing Device Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America Diabetic Lancing Device Sales Growth Rate 2015-2020 (K Units) Figure 38. North America Diabetic Lancing Device Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America Diabetic Lancing Device Sales Market Share by Country in 2019 Figure 40. North America Diabetic Lancing Device Revenue Market Share by Country in 2019 Figure 41. U.S. Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 42. U.S. Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 44. Canada Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe Diabetic Lancing Device Sales Growth Rate 2015-2020 (K Units) Figure 46. Europe Diabetic Lancing Device Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Diabetic Lancing Device Sales Market Share by Country in 2019 Figure 48. Europe Diabetic Lancing Device Revenue Market Share by Country in 2019 Figure 49. Germany Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 50. Germany Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 52. France Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 54. U.K. Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 56. Italy Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 58. Russia Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific Diabetic Lancing Device Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Diabetic Lancing Device Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Diabetic Lancing Device Sales Market Share by Region in 2019 Figure 62. Asia Pacific Diabetic Lancing Device Revenue Market Share by Region in 2019 Figure 63. China Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 64. China Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 70. India Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America Diabetic Lancing Device Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America Diabetic Lancing Device Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Diabetic Lancing Device Sales Market Share by Country in 2019 Figure 88. Latin America Diabetic Lancing Device Revenue Market Share by Country in 2019 Figure 89. Mexico Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa Diabetic Lancing Device Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Diabetic Lancing Device Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Diabetic Lancing Device Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Diabetic Lancing Device Revenue Market Share by Country in 2019 Figure 99. Turkey Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Diabetic Lancing Device Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E Diabetic Lancing Device Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. Diabetic Lancing Device Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us